Patent 7378550 was granted and assigned to Smithkline Beecham Limited on May, 2008 by the United States Patent and Trademark Office.
The present invention is directed to processes for the synthesis of intermediates useful in the preparation of non-nucleoside reverse transcriptase inhibitors.